KBIO COMPANY Statistics

Total Valuation

KBIO COMPANY has a market cap or net worth of KRW 31.65 billion. The enterprise value is 44.08 billion.

Market Cap	31.65B
Enterprise Value	44.08B

Important Dates

The next estimated earnings date is Wednesday, November 13, 2024.

Earnings Date	Nov 13, 2024
Ex-Dividend Date	n/a

Share Statistics

KBIO COMPANY has 115.50 million shares outstanding. The number of shares has increased by 25.65% in one year.

Shares Outstanding	115.50M
Shares Change (YoY)	+25.65%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	77.21M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.65
PB Ratio	0.48
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 259.84, with an EV/FCF ratio of -20.19.

EV / Earnings	-196.49
EV / Sales	0.91
EV / EBITDA	259.84
EV / EBIT	n/a
EV / FCF	-20.19

Financial Position

The company has a current ratio of 10.43, with a Debt / Equity ratio of 0.03.

Current Ratio	10.43
Quick Ratio	8.46
Debt / Equity	0.03
Debt / EBITDA	18.61
Debt / FCF	-1.45
Interest Coverage	-6.01

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Capital (ROIC)	n/a
Revenue Per Employee	1.46B
Profits Per Employee	-6.80M
Employee Count	33
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +4.18% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+4.18%
50-Day Moving Average	289.94
200-Day Moving Average	271.24
Relative Strength Index (RSI)	44.50
Average Volume (20 Days)	5,469,895

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, KBIO COMPANY had revenue of KRW 48.29 billion and -224.33 million in losses. Loss per share was -2.28.

Revenue	48.29B
Gross Profit	6.59B
Operating Income	-601.94M
Pretax Income	1.27B
Net Income	-224.33M
EBITDA	169.63M
EBIT	-601.94M
Loss Per Share	-2.28

Full Income Statement

Balance Sheet

The company has 46.45 billion in cash and 3.16 billion in debt, giving a net cash position of 43.30 billion or 374.86 per share.

Cash & Cash Equivalents	46.45B
Total Debt	3.16B
Net Cash	43.30B
Net Cash Per Share	374.86
Equity (Book Value)	122.17B
Book Value Per Share	575.29
Working Capital	58.00B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -2.15 billion and capital expenditures -37.66 million, giving a free cash flow of -2.18 billion.

Operating Cash Flow	-2.15B
Capital Expenditures	-37.66M
Free Cash Flow	-2.18B
FCF Per Share	-18.91

Full Cash Flow Statement

Margins

Gross margin is 13.64%, with operating and profit margins of -1.25% and -0.46%.

Gross Margin	13.64%
Operating Margin	-1.25%
Pretax Margin	2.64%
Profit Margin	-0.46%
EBITDA Margin	0.35%
EBIT Margin	-1.25%
FCF Margin	-4.52%

Dividends & Yields

KBIO COMPANY does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-25.65%
Shareholder Yield	-25.65%
Earnings Yield	-0.83%
FCF Yield	-6.90%

Stock Splits

The last stock split was on April 27, 2017. It was a reverse split with a ratio of 0.1.

Last Split Date	Apr 27, 2017
Split Type	Reverse
Split Ratio	0.1

Scores

KBIO COMPANY has an Altman Z-Score of 2.69. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.69
Piotroski F-Score	n/a